rxstat › Classes › Other Nervous System Drugs

Other Nervous System Drugs: shortage status in Canada

2 of the 3 other nervous system drugs rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Fampridine (Fampyra) Partial shortage 1 of 3 reported products affected · est. return Oct 2, 2026 Riluzole (Rilutek) Partial shortage 1 of 3 reported products affected · est. return Feb 9, 2027 Tetrabenazine (Nitoman) No current shortage

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.